Hismanal (astemizole) direct-to-consumer ads
Executive Summary
Are running in many of the popular consumer magazines such as Time, Newsweek, and People. The two-page ad plus brief summary has the headline: "Good news for allergy sufferers: The first once-a- day non-drowsy allergy medicine." The ad, which was precleared by FDA, continues: "Now you can get 24-hour non-drowsy relief by taking one little tablet one time a day. Just ask your doctor about Hismanal." The other prescription nonsedating antihistamine, Marion Merrell Dow's Seldane, is usually taken twice daily. Janssen Pharmaceutica plans to run the ad through the allergy season.